Key result
CRT reduces HF mortality, with IABP serving as a viable bridge in end-stage disease.
Why the study?
Cardiac resynchronisation therapy reduces symptoms and mortality in chronic heart failure patients with systolic dysfunction and prolonged QRS, but identifying patients who benefit most requires further study.
Does Cardiac resynchronisation therapy (CRT) improve outcomes in Chronic heart failure (CHF) patients with left ventricular systolic dysfunction and prolonged QRS duration?
Does Cardiac resynchronisation therapy (CRT) improve outcomes in Chronic heart failure (CHF) patients with left ventricular systolic dysfunction and prolonged QRS duration?
CRT is an effective therapy for reducing symptoms and mortality in patients with chronic heart failure, left ventricular systolic dysfunction, and prolonged QRS duration.
Answers are grounded in this paper and cite their sources.
Supports CRT consideration in select CHF cases; leaves open need for prospective validation before broader adoption.
Cardiac resynchronisation therapy (CRT) reduces symptoms and improves left ventricular function in chronic heart failure (CHF) patients with left ventricular systolic dysfunction and prolonged QRS duration. Recent studies have demonstrated a reduction in mortality associated with CRT. When combined with an implantable cardioverter defibrillator (ICD) reduction in mortality is likely to reduce further. Cardiac resynchronisation therapy is well tolerated and free from compliance issues and therefore should be considered for all suitable patients. Identifying patients who will derive maximum benefit requires further study and has health economic implications. We review here the CRT trial evidence as well as the implantation technique and complications. We also describe a case report where an intra-aortic balloon pump was used successfully as a bridge to CRT to treat a patient with end-stage heart failure.
No takes yet. Share an insight, caveat, or question.
Behan et al. (2006) conducted a review in chronic heart failure. Cardiac resynchronisation therapy (CRT) was evaluated. Cardiac resynchronisation therapy reduces symptoms and mortality in chronic heart failure, and an intra-aortic balloon pump can serve as a successful bridge to CRT in end-stage patients.
Synapse has enriched 10 related papers. Consider them for comparative context: